Trautmann, Marcel

Sarcoma treatment in the era of molecular medicine

Grünewald, T. G., Alonso, M., Avnet, S., Banito, A., Burdach, S., Cidre‐Aranaz, F., Di Pompo, G., Distel, M., Dorado‐Garcia, H., Garcia‐Castro, J., et al. (2020) · EMBO Molecular Medicine

Sarcoma Diagnosis and TreatmentChromatin Remodeling and Cancer

Cited by 319

Prevalence of the Hippo Effectors YAP1/TAZ in Tumors of Soft Tissue and Bone

Isfort, I., Elges, S., Cyra, M., Berthold, R., Renner, M., Mechtersheimer, G., Åman, P., Larsson, O., Ratner, N., Hafner, S., et al. (2019) · Scientific Reports

Hippo pathway signaling and YAP/TAZSarcoma Diagnosis and Treatment

Cited by 35

Requirement for YAP1 signaling in myxoid liposarcoma

Trautmann, M., Cheng, Y., Jensen, P., Azoitei, N., Brunner, I., Hüllein, J., Slabicki, M., Isfort, I., Cyra, M., Berthold, R., et al. (2019) · EMBO Molecular Medicine

Hippo pathway signaling and YAP/TAZSarcoma Diagnosis and Treatment

Cited by 32